Inventor · disambiguated record
Lynda G. Tussey
Also filed as: TUSSEY LYNDA · TUSSEY LYNDA G
11 granted patents·9 pending applications·87 citations·filing 2007–2017
90Inventor score
Top patents by PatentIndex Score
20 records- 0193US8420102B2Compositions that include hemagglutininSONG LANGZHOU·Filed 2007·Granted Apr 16, 2013·26 cites·34 claims
- 0292US9056901B2Methods of making hemagglutinin proteinsVAXINNATE CORP·Filed 2013·Granted Jun 16, 2015·12 cites·60 claims
- 0391US8932598B2Fusion proteins and methods of useVAXINNATE CORP·Filed 2013·Granted Jan 13, 2015·16 cites·24 claims
- 0489US8945579B2Methods of treatment with compositions that include hemagglutininVAXINNATE CORP·Filed 2013·Granted Feb 3, 2015·6 cites·45 claims
- 0589US8932605B2Deletion mutants of flagellin and methods of useSONG LANGZHOU·Filed 2010·Granted Jan 13, 2015·9 cites·45 claims
- 0688US9109007B2MHC-I restricted epitopes containing non-natural amino acid residuesKYLE DONALD J·Filed 2011·Granted Aug 18, 2015·10 cites·10 claims
- 0787US9200042B2Flagellin fusion proteinsVAXINNATE CORP·Filed 2014·Granted Dec 1, 2015·3 cites·28 claims
- 0883US9205138B2Deletion mutants of flagellin and methods of useVAXINNATE CORP·Filed 2014·Granted Dec 8, 2015·2 cites·28 claims
- 0979US9211320B2Deletion mutants of flagellin and methods of useVAXLNNATE CORP·Filed 2014·Granted Dec 15, 2015·2 cites·41 claims
- 1075US9549972B2MHC-I restricted epitopes containing non-natural amino acid residuesPURDUE PHARMA LP·Filed 2015·Granted Jan 24, 2017·1 cites·8 claims
- 1162US10149896B2MHC-I restricted epitopes containing non-natural amino acid residuesPURDUE PHARMA LP·Filed 2017·Granted Dec 11, 2018·0 cites·9 claims
- 1262US2015232516A1Flagellin Fusion ProteinsVAXINNATE CORP·Filed 2015·Application pending·0 cites
- 1361US2015110827A1Fusion proteins and methods of useVAXINNATE CORP·Filed 2014·Application pending·0 cites
- 1460US2016220660A1Flagellin Fusion ProteinsVAXINNATE CORP·Filed 2015·Application pending·0 cites
- 1556US2016193329A1Deletion Mutants of Flagellin and Methods of UseVAXINNATE CORP·Filed 2015·Application pending·0 cites
- 1648US2013330367A1Compositions with enhanced immunogenicity and/or reduced reactogenicityVAXINNATE CORP·Filed 2013·Application pending·0 cites
- 1744US2014235836A1Immunologic Constructs and MethodsVAXINNATE CORP·Filed 2014·Application pending·0 cites
- 1843US2013095130A1Methods and Compositions for Providing Protective Immunity in the ElderlyTAYLOR DAVID·Filed 2011·Application pending·0 cites
- 1940US2014205624A1Tetravalent and mixed head bivalent dengue vaccineSONG LANGZHOU·Filed 2012·Application pending·0 cites
- 2039US2016166671A1Clostridium Difficile Compositions and Methods of UseVAXINNATE CORP·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →